Author

C. B. Anderson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Ecology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:ecology & biodiversity· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. Califano· 1 shared A. Z. Obradovic· 1 shared C. G. Drake· 1 shared C. R. Ager· 1 shared E. A. Lim· 1 shared E. A. Mordecai· 1 shared G. J. Decastro· 1 shared I. Lowy· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Califano

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Local tree cover predicts mosquito species richness and disease vector presence in a tropical countryside landscape

J. E. Farner, M. E. Howard, J. R. Smith, C. B. Anderson, E. A. Mordecai

The paper examines how local tree cover affects mosquito species richness and disease vector presence in tropical landscapes, finding tree cover supports biodiversity and reduces vector presence at small spatial scales.

Landscape Ecology · May 28, 2025Peer-reviewedEcology

Single-Cell RNAseq Analysis Reveals Robust Anti-PD-1-Mediated Increase of Immune Infiltrate in Metastatic Castration-Sensitive Prostate Cancer

J. E. Hawley, A. Z. Obradovic, M. C. Dallos, E. A. Lim, K. Runcie, C. R. Ager, J. M. McKiernan, C. B. Anderson, G. J. Decastro, J. L. Weintraub, R. K. Virk, I. Lowy, J. Hu, M. G. Chaimowitz, X. V. Guo, , C. G. Drake

The paper analyzes single-cell RNAseq data from metastatic castration-sensitive prostate cancer patients treated with anti-PD-1 immunotherapy, showing increased immune infiltrate and identifying therapy-resistant tumor subpopulations and druggable targets.

bioRxiv · May 6, 2022 · PreprintCancer Biology